Obesity
Weight gain of 10% or more common among breast cancer survivors
BOSTON — Breast cancer survivors are more likely to have weight gain of 10% or more during follow-up compared with healthy controls, with the strongest predictors younger age at diagnosis and lower weight at baseline, data show.
Single excess weight measurement ‘does not seal one’s fate’ for heart-related events
BOSTON — Younger adults are at greater cardiovascular disease risk if they have obesity for 10 years, but a single excess weight measurement does not predict risk for heart-related events over time, according to data presented at ENDO 2024.
Semaglutide may change perception, brain response to sweet tastes
BOSTON — In a proof-of-concept study, women with obesity who took semaglutide reported enhanced taste perception, and researchers observed altered gene expression in their tongues and their brain reward response related to sweet tastes.
Sedentary children risk liver disease in young adulthood
BOSTON — Accumulating sedentary time during childhood was associated with increased risk for liver disease in young adulthood, but boosting light physical activity may lessen the risk, according to data presented at ENDO 2024.
Insurance denials may pose substantial barrier to GLP-1 drugs for teens
BOSTON — From 2019 to 2023, insurance covered GLP-1 receptor agonist prescriptions at a Texas hospital for less than 70% of young people with type 2 diabetes and less than 40% of those with obesity.
Adults with class II to III obesity may have increased cardiac outcomes
Adults with class II to III obesity may have an increased risk for poor cardiac outcomes but not kidney risk after adjusting for potential confounders, according to multicenter data.
Priorities in obesity, CVD risk: optimizing body weight, atherogenic lipid levels
Patients with obesity are at increased risk for CVD, in part due to the promotion of an atherogenic lipid profile, according to a speaker.
New vitamin D consensus guideline, debates highlight ENDO annual meeting
Endocrinology providers and researchers will gather in Boston beginning Saturday as the Endocrine Society holds its 2024 annual meeting.
Weight gain during diet therapy linked to ‘worse EoE outcomes’ no matter baseline weight
WASHINGTON — Among adults with eosinophilic esophagitis, weight gain while undergoing dietary therapy was associated with poor treatment response, regardless of baseline weight status, according to data presented at Digestive Disease Week.
Youth with higher adiposity may be more susceptible to cognitive effects of poor sleep
Insufficient sleep was tied to poorer cognition and attention in adolescents who were classified as having overweight or obesity based on their BMI compared with those with normal weight, according to a recent study in JAMA Neurology.